HIV-1 specific T-cell immunity

"HIV-1 specific T-cell immunity" does **not** refer to a single molecular target, receptor, or protein, but instead describes a type of immune response—specifically, T-cell-mediated recognition and response to HIV-1 antigens. Both CD4+ and CD8+ T cells can participate in this response, which comprises the detection and killing of HIV-infected cells, the production of cytokines, and the regulation of immunity against HIV-1[2][3][5]. This immunity is especially relevant in understanding why some individuals exposed to HIV-1 do not become infected, as well as in vaccine design and assessment of immune correlates of protection[1][6][7]. **Key clarification:** "HIV-1 specific T-cell immunity" is a functional/phenotypic description, **not** an identifiable protein, receptor, or canonical drug target. It refers broadly to the presence and activity of T cells (particularly CD8+ cytotoxic T lymphocytes and, to a lesser extent, CD4+ helper T cells) that are specific for peptides derived from HIV-1 proteins[2][3][6]. These T cells recognize infected cells via T-cell receptors engaging HIV peptide–HLA complexes but are not themselves a molecular target that could be directly modulated by a small molecule or antibody therapy. **Conclusion:** The entry "HIV-1 specific T-cell immunity" does not correspond to a canonical molecule or receptor and should be flagged as incorrect for the purposes of standardized molecular drug target data structures.

Other names

HIV-1–specific T-cell responseHIV-1–specific cell-mediated immunityHIV-1–specific cytotoxic T-cell response